New FDA-Approved Pill Potentially Doubles Pancreatic Cancer Survival Time
The FDA has officially approved Rasonque, a groundbreaking new daily pill that targets a specific genetic mutation to treat deadly pancreatic cancer. Medical experts say this massive breakthrough provides new hope for patients, with clinical trials showing the drug can double the average survival time.
Top Videos
New FDA-Approved Pill Potentially Doubles Pancreatic Cancer Survival Time
Houston weather: Rain returns to the forecast for Friday
CAUGHT ON CAMERA: Food delivered by naked man in Houston
Convicted serial burglar caught for the ninth time
Screwworm rise threatens Texas pet rescues
President Trump arrives in Houston for Thursday private fundraiser, NASA event
The Woodlands preparing to pay millions to Houston to block future annexation
Son in custody for father's stabbing death in Harris County
"Process Upset" causes flaring at Baytown facility
FULL VIDEO: Baytown facility sends plumes of black smoke into the air
Mother speaks out following terrifying shooting in Houston
Owners upset paying high HOA fees for condos uninhabitable for more than 5 years
Houston weather: Rain chances returning to the forecast
Judge issues ruling regarding Texas's restrictions to drag shows
Residents complain about lights being out at Northlake Manor Apartments
Suspect featured in "Breaking Bond" report responds
Conversation with Democratic Candidate for TX-09 Race
Meta agrees to settlement with 47 states in lawsuits
Houston Theater Week celebrates five years with BOGO ticket deals
KENNEDY CENTER FACES RENOVATION OR DEMOLITION | D.C. Daily
Isiah Factor: Uncensored Producer Finds Destroyed Flock Camera in Houston's Galleria
Houston Uber Driver Breaks Down the Moment Cops Hijacked His Car
Career criminal granted bond despite warrants
Houston rancher sees sales triple following President Trump's beef import announcement
Judge orders release of deadly Houston ICE shooting witness
